According to Nova one advisor, the global Proteomics market size accounted for USD 22.90 billion in 2022 and is estimated to achieve a market size of USD 70.65 billion by 2030 growing at a CAGR of 13.19% from 2022 to 2030.
According to Nova one advisor, the global Proteomics market size accounted for USD 22.90 billion in 2022 and is estimated to achieve a market size of USD 70.65 billion by 2030 growing at a CAGR of 13.19% from 2022 to 2030.
Get the Free Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/7577
Key Takeaways:
- The reagent & consumables product segment held the largest share in 2021 due to rising research activities and the growing demand for protein separation from complicated mixtures for efficient analysis
- The clinical diagnostics application segment held a larger share in 2021 due to the development of sophisticated & specialized tests for early disease detection and disease management
- The spectroscopy technology segment held the maximum share in 2021 owing to the increasing usage in toxicological response profiling, basic molecular biology, biomarker identification, and pharmaceutical target screening
- North America led the global industry in 2021 due to a rise in demand for personalized drugs, the existence of major players operating in the U.S. and a highly developed healthcare research framework, and substantial expenditure on R&D
- Asia Pacific is expected to grow at the highest CAGRoverthe projected period due to factors, such as the rising prevalence of target diseases, increasing aging population, and rising proteomics adoption
Report Scope of the Proteomics Market
| Report Coverage | Details |
| Market Size | USD 70.65 Billion by 2030 |
| Growth Rate | CAGR of 13.19% from 2022 to 2030 |
| Largest Market | Asia Pacific |
| Fastest Growing Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, application, technology, and Region, |
Immediate Delivery Available | Buy this Premium Research Report@ https://www.novaoneadvisor.com/report/checkout/7577
The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.
The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.
In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.
Regional Insights
North America dominated the industry with the largest revenue share of 46.01% in 2021. This is attributed to the increased investments in the development of structure-based drug design, growth in omics research, demand for high-quality research tools for data reproducibility, and attention to the development of tailored treatments. The expansion of this market is also being aided by the partnerships and collaborations amongmajor companies in this region. For instance, Thermo Fisher Scientific Inc. and Symphogen collaborated to develop verified platform processes for the streamlined characterization and quality monitoring of complex therapeutic proteins.
This continued agreement was announced in March 2022.The Asia Pacific region is estimated to grow at the fastest CAGR from 2022 to 2030 due to an increase in outsourcing of proteomics-based projects, public and private funding for research and development for proteomics studies, favorable government regulations, rising prevalence of target diseases with an aging population, and rising proteomics adoption. For instance, the University of Hyderabad received 60 million in funding from the Department of Biotechnology of the Indian government in November 2021 to study the proteome of tomatoes. The market in Asia Pacific is being driven by such government measures to support the proteomics study.
Some of the prominent players in the Proteomics Market include:
- Illumina, Inc.
- Agilent Technologies, Inc.
- Bio - Rad Laboratories, Inc.
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- F. Hoffmann-La Roche Ltd.
- Promega Corp.
- Merck KGaA.
- Danaher
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Proteomics market
- Product Scope
- Instruments
- Reagents & Consumables
- Services
- Application Scope
- Drug Discovery
- Clinical diagnostics
- Others
- Technology Scope
- Microarray Instruments
- X-Ray Crystallography
- Spectroscopy
- Chromatography
- Protein Fractionation Systems
- Electrophoresis
- Surface Plasma Resonance (SPR) Systems
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7577
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
Blog: https://qyresearchmedical.com/